CollPlant Biotechnologies Ltd - Ordinary Shares New

NASDAQ:CLGN   3:59:53 PM EDT
9.95
+0.35 (+3.65%)
Earnings Announcements

Collplant Reports Q2 Non-GAAP Loss Per Share Of $0.25

Published: 08/19/2021 11:52 GMT
CollPlant Biotechnologies Ltd - Ordinary Shares New (CLGN) - Q2 Non-GAAP Loss per Share $0.25.
Q2 GAAP Loss per Share $0.30.
Q2 Revenue $691,000.
Revenue is expected to be $2.74 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $2.86 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.